{"id":"https://openalex.org/W2952091405","doi":"https://doi.org/10.1021/jm00019a009","title":"Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines","display_name":"Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines","publication_year":1995,"publication_date":"1995-09-01","ids":{"openalex":"https://openalex.org/W2952091405","doi":"https://doi.org/10.1021/jm00019a009","mag":"2952091405","pmid":"https://pubmed.ncbi.nlm.nih.gov/7562910"},"language":"en","primary_location":{"id":"doi:10.1021/jm00019a009","doi":"https://doi.org/10.1021/jm00019a009","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00019a009","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052708209","display_name":"Aleem Gangjee","orcid":"https://orcid.org/0000-0002-5513-7616","observed_orcids":["https://orcid.org/0000-0002-5513-7616"]},"institutions":[{"id":"https://openalex.org/I165102784","display_name":"Duquesne University","ror":"https://ror.org/02336z538","country_code":"US","type":"education","lineage":["https://openalex.org/I165102784"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aleem Gangjee","raw_affiliation_strings":["Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, USA","institution_ids":["https://openalex.org/I165102784"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079190905","display_name":"Rajesh V. Devraj","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajesh Devraj","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091214681","display_name":"John J. McGuire","orcid":"https://orcid.org/0000-0003-0302-3884","observed_orcids":["https://orcid.org/0000-0003-0302-3884"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John J. McGuire","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5052492275","display_name":"Roy L. Kisliuk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roy L. Kisliuk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.1729,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.75821974,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"38","issue":"19","first_page":"3798","last_page":"3805"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9146000146865845,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9146000146865845,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.06279999762773514,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antifolate-analogues","display_name":"antifolate analogues","score":0.6819999814033508},{"id":"https://openalex.org/keywords/dihydrofolate-reductase-inhibitors","display_name":"dihydrofolate reductase inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/thymidylate-synthase-inhibitors","display_name":"thymidylate synthase inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ccrf-cem-cells","display_name":"CCRF-CEM cells","score":0.8220000267028809},{"id":"https://openalex.org/keywords/lacticaseibacillus-casei","display_name":"Lactobacillus casei","score":0.9359999895095825},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8240000009536743},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.7260000109672546}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.927815318107605},{"id":"https://openalex.org/C2781382166","wikidata":"https://www.wikidata.org/wiki/Q50573407","display_name":"Antifolate","level":4,"score":0.8329871892929077},{"id":"https://openalex.org/C100776233","wikidata":"https://www.wikidata.org/wiki/Q2532492","display_name":"Bridge (graph theory)","level":2,"score":0.6214634776115417},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5332479476928711},{"id":"https://openalex.org/C2778334786","wikidata":"https://www.wikidata.org/wiki/Q1586270","display_name":"Variation (astronomy)","level":2,"score":0.4877956211566925},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18453776836395264},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1476609706878662},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.12503769993782043},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.0642528235912323},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C44870925","wikidata":"https://www.wikidata.org/wiki/Q37547","display_name":"Astrophysics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005492","descriptor_name":"Folic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005492","descriptor_name":"Folic Acid","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D005492","descriptor_name":"Folic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005492","descriptor_name":"Folic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007042","descriptor_name":"Hypoxanthines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007780","descriptor_name":"Lacticaseibacillus casei","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010453","descriptor_name":"Peptide Synthases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D010453","descriptor_name":"Peptide Synthases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013936","descriptor_name":"Thymidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013940","descriptor_name":"Thymidylate Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013940","descriptor_name":"Thymidylate Synthase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019271","descriptor_name":"Hypoxanthine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm00019a009","doi":"https://doi.org/10.1021/jm00019a009","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00019a009","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:7562910","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7562910","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1731754422","display_name":"FOLYLPOLYGLUTAMATE SYNTHETASE IN CANCER CHEMOTHERAPY","funder_award_id":"R01CA043500","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5254093300","display_name":"SYNTHESIS OF RIGID ANALOGS RELATED TO TRIMETREXATE","funder_award_id":"R01GM040998","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G5791084355","display_name":"TRICYCLIC ANALOGUES OF TRIMETREXATE AND PIRITREXIM","funder_award_id":"R55AI030900","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2080098763","https://openalex.org/W2800118097","https://openalex.org/W1982669395","https://openalex.org/W2025813955","https://openalex.org/W1966430390","https://openalex.org/W2086998184","https://openalex.org/W2083922408","https://openalex.org/W2063372916","https://openalex.org/W1984924779","https://openalex.org/W1995599191"],"abstract_inverted_index":{"Variation":[0],"of":[1,11,24,62,66,82,93,109,152,177,191,197,200,210,233,238,244,284],"the":[2,5,63,79,90,175,198,234,241,264],"bridge":[3],"linking":[4],"heterocyclic":[6],"ring":[7],"and":[8,18,28,32,38,46,69,76,99,117,147,150,286],"p-aminobenzoyl-L-glutamate":[9],"portions":[10],"our":[12],"previously":[13],"described":[14],"classical":[15],"2,4-diaminofuro[2,3-d]pyrimidines":[16],"1":[17],"2":[19],"are":[20],"reported":[21],"as":[22,33,107],"inhibitors":[23,108],"dihydrofolate":[25],"reductase":[26],"(DHFR)":[27],"thymidylate":[29],"synthase":[30],"(TS)":[31],"antitumor":[34],"agents.":[35],"Specifically":[36],"-CH2CH2-":[37],"-CH2NHCH2-":[39],"bridged":[40],"analogues,":[41],"N-[4-[2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)":[42],"ethyl]benzoyl]-L-glutamic":[43],"acid":[44,49],"(3)":[45],"N-[4-[[N-[(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)":[47],"methyl]amino]methyl]benzoyl]-L-glutamic":[48],"(4),":[50],"respectively,":[51],"were":[52,103,139,151],"synthesized.":[53],"Compound":[54,85,120,128,172],"3":[55,121,173,214,239,262],"was":[56,87,130,162,215,254,274],"obtained":[57],"via":[58],"a":[59,188,216,282],"Wittig":[60],"reaction":[61],"tributylphosphonium":[64],"salt":[65],"2,4-diamino-5-(chloromethyl)furo[2,3-d]pyrimidine":[67],"(5)":[68],"methyl":[70],"4-formylbenzoate":[71],"(6)":[72],"followed":[73],"by":[74,89,204,277,281],"reduction":[75],"coupling":[77],"with":[78,95,248,261],"diethyl":[80,96],"ester":[81],"L-glutamic":[83],"acid.":[84],"4":[86,129,161,186],"synthesized":[88],"nucleophilic":[91],"displacement":[92],"5":[94],"N-[4-(aminomethyl)benzoyl]-L-glutamate":[97],"(15)":[98],"saponification.":[100],"Both":[101],"analogues":[102],"evaluated":[104,141],"in":[105,180,263],"vitro":[106],"DHFRs":[110],"from":[111,144,225],"(recombinant)":[112,145],"human,":[113],"human":[114,146,167,220],"CCRF-CEM":[115,202,211,226,245],"cells,":[116],"Lactobacillus":[118],"casei.":[119],"showed":[122,187],"moderate":[123],"activity":[124,154,237],"(IC50":[125,133,155,182],"10(-6)-10(-7)":[126],"M).":[127,157],"essentially":[131],"inactive":[132],"10(-5)":[134,156],"M,":[135],"CCRF-CEM).":[136],"The":[137,158,195],"compounds":[138,206],"also":[140],"against":[142,240],"TS":[143,168],"L.":[148],"casei":[149],"low":[153,189],"three-atom-bridged":[159],"analogue":[160],"somewhat":[163],"more":[164],"inhibitory":[165,193,236],"to":[166],"than":[169],"methotrexate":[170],"(MTX).":[171],"inhibited":[174],"growth":[176,192,199,235],"tumor":[178],"cells":[179,203,227,246],"culture":[181],"10(-7)":[183],"M)":[184],"while":[185],"level":[190],"activity.":[194],"inhibition":[196,209,273],"leukemia":[201],"both":[205],"parallels":[207],"their":[208],"DHFR.":[212,294],"Analogue":[213],"good":[217],"substrate":[218],"for":[219,256],"folylpolyglutamate":[221],"synthetase":[222],"(FPGS)":[223],"derived":[224],"(Km":[228],"8.5":[229],"microM).":[230],"Further":[231],"evaluation":[232],"MTX-resistant":[242],"subline":[243],"(R30dm)":[247],"decreased":[249],"FPGS":[250],"indicated":[251,271],"that":[252,272],"poly-gamma-glutamylation":[253],"important":[255],"its":[257],"action.":[258],"Protection":[259],"studies":[260],"FaDu":[265],"squamous":[266],"cell":[267,269],"carcinoma":[268],"line":[270],"completely":[275],"reversed":[276],"leucovorin":[278],"[(6R,S-5-formyltetrahydrofolate]":[279],"or":[280],"combination":[283],"thymidine":[285],"hypoxanthine,":[287],"suggesting":[288],"an":[289],"antifolate":[290],"effect":[291],"directed":[292],"at":[293]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2019-06-27T00:00:00"}